MedTrace Logo

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

NCT05005650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2023-06-26

No results posted yet for this study

Summary

To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.

Conditions

  • Ovarian Cancer Stage IV
  • Lymph Node Metastases

Interventions

PROCEDURE

debulking surgery

debulking surgery as primary debulking surgery or interval debulking surgery

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee Seung Kim, Pf · Seoul National University Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-08-31
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05005650 on ClinicalTrials.gov